NCT03150316 - CKD-581 + Lenalidomide + Dexamethasone in Patients With Previously Treated Multiple Myeloma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 10, 2017

Primary Completion Date

June 30, 2020

Study Completion Date

September 30, 2021

Conditions

Myeloma, Multiple

Interventions

DRUG

Treat Regimen

CKD-581(investigational Drug): on days 1, 8, 15 of repeated 28day cycles Lenalidomide: on days 1\~21 of repeated 28 day cycles Dexamethasone: administrated once weekly every 28day cycles

Trial Locations (2)

06351

RECRUITING

Samsung Hospital, Seoul

06591

RECRUITING

the catholic university of korea, Seoul ST. Mary's Hospital, Seoul